Liraglutide reduces attenuation coefficient as a measure of hepatic steatosis during 16 weeks' treatment in nondiabetic obese patients: A pilot trial is a research paper published in JGH Open (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21‐DK121943
National Institutes of Health
Grant: RO1‐DK67071
NIDDK NIH HHS
Grant: R21 DK121943
NIDDK NIH HHS
Grant: R01 DK067071
NIDDK NIH HHS
Grant: R56 DK067071
National Institutes of Health
Grant: 1R21DK121943-01A1
Ultrasound Evaluation of Liver Steatosis
National Institutes of Health
Grant: 5R01DK067071-15
Effects of Liraglutide on Gastric Functions and their Relationship to Weight Loss in Obesity
FWCI
0.65
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals